Palvella Stock: First Approval Could Unlock Rare-Disease Commercial Flywheel (PVLA)
· seekingalpha.com
Palvella (PVLA) advances QTORIN rapamycin with Phase 3 SELVA data and a rolling NDA. Read here for a detailed investment analysis.
Palvella ( PVLA ) is building out a repeatable regulatory and commercial platform (the QTORIN platform) using the same topical delivery technology, with an over...